Please ensure Javascript is enabled for purposes of website accessibility

World Health Organization: Coronavirus Disease COVID-19 Now a Pandemic

By Keith Speights - Updated Mar 11, 2020 at 4:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The growing number of cases worldwide of COVID-19 spurred the international health agency to elevate the seriousness of the threat.

World Health Organization (WHO) director-general Tedros Adhanom Ghebreyesus officially declared COVID-19, the disease caused by the novel coronavirus, a pandemic on Wednesday. COVID-19 had previously been designated as a global health emergency in January after the number of cases of the virus soared in China.

From epidemic to pandemic

An epidemic occurs when a disease affects many people with the number of cases above what would be normally expected. A pandemic occurs when an epidemic spreads across the world and affects a large number of people.

WHO officials have carefully avoided directly calling the COVID-19 outbreak as a pandemic until today. They have come close, though, with Ghebreyesus stating on Monday that "the threat of a pandemic has become very real."

Hands holding small globe with a mask around the globe that has "coronavirus" written on it

Image source: Getty Images.

Now, however, the sheer scale of the numbers has prompted WHO to declare COVID-19 as a pandemic. There have been more than 120,000 people in at least 114 countries who have been infected by the novel coronavirus. So far, more than 4,000 individuals across the world have died from COVID-19.

What's next?

Governments and private companies are scrambling to develop vaccines and treatments for COVID-19. Gilead Sciences (GILD 0.90%) appears to be in the lead position in testing a potential antiviral treatment for the disease. The big biotech is currently conducting two late-stage clinical studies evaluating remdesevir in treating COVID-19. Several drugmakers are also rushing to test experimental COVID-19 vaccines.

In the meantime, health experts recommend washing hands with soap and water for at least 20 seconds and limiting contact with others to reduce the chances of exposure to the coronavirus.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$63.84 (0.90%) $0.57

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.